In vitro and in vivo cardiac toxicity of flavored electronic nicotine delivery systems.
Nonclinical
Cardiovascular Toxicity
Both
abouassali (2021)
Electronic cigarette extract induced toxic effect in iPS-derived cardiomyocytes.
Nonclinical
Cardiovascular Toxicity
In Vivo
Basma (2020)
Differential impact of JUUL flavors on pulmonary immune modulation and oxidative stress responses in male and female mice.
Nonclinical
Cardiovascular Toxicity
In Vivo
Been (2022)
E-cigarette vaping liquids and the flavoring chemical cinnamaldehyde perturb bone, cartilage and vascular development in zebrafish embryos.
Nonclinical
Cardiovascular Toxicity
In Vivo
Bhattacharya (2021)
E-Cigarette aerosol Condensate Leads to Impaired Coronary Endothelial Cell health and Restricted angiogenesis.
Nonclinical
Cardiovascular Toxicity
In Vitro
Chhor (2023)
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model.
Nonclinical
Cardiovascular Toxicity
In Vitro
Dai (2023)
E-cigarette effects on vascular function in animals and humans.
Nonclinical
Cardiovascular Toxicity
In Vitro
Daiber (2023)
Electronic cigarette exposure causes vascular endothelial dysfunction due to NaDPh oxidase activation and eNOS uncoupling.
Nonclinical
Cardiovascular Toxicity
In Vivo
El-Mahdy (2022)
Nicotine and novel tobacco products drive adverse cardiac remodeling and dysfunction in preclinical studies.
Nonclinical
Cardiovascular Toxicity
In Vivo
Fried (2022)
addressing the challenges of E-cigarette safety profiling by assessment of pulmonary toxicological response in bronchial and alveolar mucosa models.
Nonclinical
Cardiovascular Toxicity
In Vitro
Ganguly (2020)